These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 32526980)
1. The Role of ERα36 in Development and Tumor Malignancy. Thiebaut C; Konan HP; Guerquin MJ; Chesnel A; Livera G; Le Romancer M; Dumond H Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526980 [TBL] [Abstract][Full Text] [Related]
2. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression. Chamard-Jovenin C; Jung AC; Chesnel A; Abecassis J; Flament S; Ledrappier S; Macabre C; Boukhobza T; Dumond H BMC Syst Biol; 2015 Jun; 9():28. PubMed ID: 26080803 [TBL] [Abstract][Full Text] [Related]
3. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells. Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224 [TBL] [Abstract][Full Text] [Related]
4. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer. Garan LAW; Xiao Y; Lin WC Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209211119. PubMed ID: 36252018 [TBL] [Abstract][Full Text] [Related]
5. Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression. Thiebaut C; Chamard-Jovenin C; Chesnel A; Morel C; Djermoune EH; Boukhobza T; Dumond H PLoS One; 2017; 12(3):e0173931. PubMed ID: 28301550 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer. Maczis MA; Maceyka M; Waters MR; Newton J; Singh M; Rigsby MF; Turner TH; Alzubi MA; Harrell JC; Milstien S; Spiegel S J Lipid Res; 2018 Dec; 59(12):2297-2307. PubMed ID: 30315000 [TBL] [Abstract][Full Text] [Related]
7. Expression and localization of estrogen receptor in human breast cancer and its clinical significance. Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640 [TBL] [Abstract][Full Text] [Related]
8. Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics. Mahboobifard F; Bidari-Zerehpoosh F; Davoudi Z; Panahi M; Dargahi L; Pourgholami MH; Sharifi G; Izadi N; Jorjani M Pituitary; 2020 Jun; 23(3):232-245. PubMed ID: 32026205 [TBL] [Abstract][Full Text] [Related]
9. Tamoxifen enhances stemness and promotes metastasis of ERα36 Wang Q; Jiang J; Ying G; Xie XQ; Zhang X; Xu W; Zhang X; Song E; Bu H; Ping YF; Yao XH; Wang B; Xu S; Yan ZX; Tai Y; Hu B; Qi X; Wang YX; He ZC; Wang Y; Wang JM; Cui YH; Chen F; Meng K; Wang Z; Bian XW Cell Res; 2018 Mar; 28(3):336-358. PubMed ID: 29393296 [TBL] [Abstract][Full Text] [Related]
10. An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism. Ajj H; Chesnel A; Pinel S; Plenat F; Flament S; Dumond H PLoS One; 2013; 8(4):e61758. PubMed ID: 23626723 [TBL] [Abstract][Full Text] [Related]
11. Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells. Thiebaut C; Chesnel A; Merlin JL; Chesnel M; Leroux A; Harlé A; Dumond H Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146345 [TBL] [Abstract][Full Text] [Related]
12. The role of ERα36 in cell type-specific functions of estrogen and cancer development. Mahboobifard F; Dargahi L; Jorjani M; Ramezani Tehrani F; Pourgholami MH Pharmacol Res; 2021 Jan; 163():105307. PubMed ID: 33246174 [TBL] [Abstract][Full Text] [Related]
13. A Role for Estrogen Receptor alpha36 in Cancer Progression. Pagano MT; Ortona E; Dupuis ML Front Endocrinol (Lausanne); 2020; 11():506. PubMed ID: 32849292 [TBL] [Abstract][Full Text] [Related]
14. ERα36--Another piece of the estrogen puzzle. Sołtysik K; Czekaj P Eur J Cell Biol; 2015 Dec; 94(12):611-25. PubMed ID: 26522827 [TBL] [Abstract][Full Text] [Related]
15. Clinical and Biological Significance of Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757 [TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor α variants and c-Fos in rat mammary gland and tumors. Gutiérrez A; Sambuco L; Álvarez L; Núñez M; Bergoc R; Zotta E; Martín G; Randi A J Steroid Biochem Mol Biol; 2020 May; 199():105594. PubMed ID: 31968225 [TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance. Song T; Zhang H; Zhao Q; Hu Z; Wang Z; Song Y; Zhang Z Breast Cancer Res; 2024 Feb; 26(1):33. PubMed ID: 38409088 [TBL] [Abstract][Full Text] [Related]
18. Structural insights into tumor-specific chaperoning activity of gamma synuclein in protecting estrogen receptor alpha 36 and its role in tamoxifen resistance in breast cancer. Panneerselvam M; Muthu K; Ramadas K Mol Biosyst; 2015 Nov; 11(11):2998-3010. PubMed ID: 26299756 [TBL] [Abstract][Full Text] [Related]
19. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines. Pelekanou V; Notas G; Kampa M; Tsentelierou E; Radojicic J; Leclercq G; Castanas E; Stathopoulos EN Steroids; 2012 Aug; 77(10):928-34. PubMed ID: 22198466 [TBL] [Abstract][Full Text] [Related]
20. The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer. Verma A; Cohen DJ; Jacobs TW; Boyan BD; Schwartz Z Mol Cancer Res; 2021 Jan; 19(1):99-111. PubMed ID: 33082240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]